Wealth Enhancement Advisory Services
TGTX icon

Wealth Enhancement Advisory Services’s TG Therapeutics TGTX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$529K Buy
25,159
+7,042
+39% +$288K ﹤0.01% 2631
2026
Q1 		$128K Sell
18,117
-1,880
-9% -$56K ﹤0.01% 3264
2025
Q4 		$581K Buy
19,997
+250
+1% +$8.16K ﹤0.01% 2366
2025
Q3 		$721K Buy
+19,747
New +$650K ﹤0.01% 2078

Other funds holding TGTX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Wealth Enhancement Advisory Services's TGTX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its TG Therapeutics (TGTX) stake by 39% in Q2 2026, buying an estimated $288K and bringing the position to 25,159 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

Wealth Enhancement Advisory Services first reported a position in TGTX in Q3 2025 and has held it in 4 quarters since. The position peaked at $721K in Q3 2025. 74 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 25,159 shares of TG Therapeutics worth $529K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 7,042 TG Therapeutics shares in Q2 2026, an estimated $288K.
  • TG Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2631 holding.
  • Wealth Enhancement Advisory Services first reported a position in TG Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's TG Therapeutics position peaked at $721K in Q3 2025.
  • 74 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.